Highlights
NYSE: ZTS       Zoetis Inc Cl A
Last Price Today's Change   Day's Range   Trading Volume
144.00   0.00 (0.00%)  0.00 - 0.00  0

Overview

 
Avg Volume (4 weeks):2,401,647
4 Weeks Range:142.22 - 170.07
4 Weeks Price Volatility (%):
84.67%
52 Weeks Range:90.14 - 176.64
52 Weeks Price Volatility (%):
81.52%
Average Price Target: 42.00
Price Target Upside/Downside: -102.00

Headlines



No recent Headlines for this stock.


Business Background

Zoetis Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals. The Company's segments include the United States and International. Within each of these operating segments, it offers a product portfolio for both livestock and companion animal customers. Its livestock products include Ceftiofur injectable line, Draxxin, Spectramast, Bovi-Shield line, Rispoval line, Suvaxyn/Fostera, Embrex devices and Lutalyse. Its companion animal products include Clavamox/Synulox, Convenia, ProHeart, Revolution/Stronghold, Apoquel, Cerenia and Rimadyl.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

10003 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 KSMT 9.920.00 
 HIPS 14.210.00 
 HONE 12.780.00 
 ENZL 62.220.00 
 KOD 111.670.00 
 UPRO 77.240.00 
 COLD 34.050.00 
 ALYA 2.160.00 
 CIGI 102.490.00 
 AXNX 55.680.00 

TOP ARTICLES

1. Equities Sunk as Yields Jumped, Again State of The Markets
2. Daily Futures Trading Strategy 5 March 2021 Where Futures Lies
3. CryptoNews of the Week CryptoNews
4. Wall Street Breakfast: Vaccine Overdrive Wall Street Breakfast
5. Markets Cautious Amid Safe Haven Flows State of The Markets